SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
SEC Accession No. 0001213900-20-043808
Filing Date
2020-12-21
Accepted
2020-12-21 16:21:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO PRELIMINARY PROXY STATEMENT ea132028-prrn14a_roumell.htm PRRN14A 288684
2 GRAPHIC image_001.jpg GRAPHIC 13124
3 GRAPHIC image_002.jpg GRAPHIC 13124
4 GRAPHIC image_003.jpg GRAPHIC 13124
5 GRAPHIC image_004.jpg GRAPHIC 65524
6 GRAPHIC image_005.jpg GRAPHIC 116122
  Complete submission text file 0001213900-20-043808.txt   595247
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: PRRN14A | Act: 34 | File No.: 001-09974 | Film No.: 201404564
SIC: 8071 Services-Medical Laboratories

Mailing Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

IRS No.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: PRRN14A